Checked, not settled
Checks out so far.
“In the phase II randomized RIO trial of 68 adult men living with HIV who interrupted ART, long-acting 3BNC117-LS and 10-1074-LS delayed viral rebound: median ART restart was 45.4 weeks with antibodies versus 4.6 weeks with placebo, and intact proviruses declined in the antibody arm.”
3 of 4 review checks done · 1 counted · 2 by the author only
Supported · 0.9468 under ledger-default@0.3.0 at snapshot 27745 · review checks 1 of 4 · provisional until audited. The number is model-conditional, not a share of truth.
Share:
Checked in Galedra: score 0.95, strongly supported · not yet reviewed by anyone else
“In the phase II randomized RIO trial of 68 adult men living with HIV who interrupted ART, long-acting 3BNC117-LS and 10-1074-LS delayed viral rebound: median ART restart was 45.4 weeks with…”
https://galedra.org/claims/48e36fc0-52e3-80ab-8a44-4ad71304f296/card
Or just the link: https://galedra.org/claims/48e36fc0-52e3-80ab-8a44-4ad71304f296/card
See the evidence · 
Galedra